CTD Announces Continuation of Expanded Access Program in Single Alzheimer’s Patient
Favorable risk/benefit analysis outlined in report to FDA ALACHUA, FL / ACCESSWIRE / June 10, 2019 / CTD Holdings, Inc....
user
New Jersey Lasik Surgeon Dr. Steven W. Stetson Returns to Paramus for Patient Surgeries
Dr. Stetson, Who is Medical Director of Diamond Vision, is Again Seeing Patients and Performing Surgery at the Paramus Office...
David Appell Joins Parallax Health Sciences, Inc. as Chief Operating Officer
Mr. Appell brings over twenty years of experience in building high volume transactional-related platforms to deliver large revenue streams SANTA...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019
Parnell Delivers 9% Revenue Growth in Quarter 1 of 2019 Compared to 2018, and Confirms Provisional 2019 Guidance for a...
DECN Discusses Propositions Received For Its GenUltimate TBG
LOS ANGELES, CA / ACCESSWIRE / June 7, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year...
MPPs to Pack Medicines for Refugees
OAKVILLE, ON / ACCESSWIRE / June 7, 2019 / Health Partners International of Canada (HPIC) will be hosting a delegation...
Arcutis, Inc. Appoints Scott Burrows as Vice President, Finance
WESTLAKE VILLAGE, CA / ACCESSWIRE / June 6, 2019 / Arcutis, Inc., a privately held immuno-dermatology drug development company addressing...
How Blockchain Can Boost Your Health
HONG KONG, CHINA / ACCESSWIRE / June 6, 2019 / Young, elderly, man, woman, dumb, wise, rich or poor no...
Streamline Health to Report First Quarter 2019 Financial Performance on June 12, 2019
ATLANTA, GA / ACCESSWIRE / June 5, 2019 / Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled...
Adial Pharmaceuticals and Tedor Pharma Announce Collaboration to Manufacture AD04 Through Commercialization
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 CHARLOTTESVILLE, VA / ACCESSWIRE / June 6, 2019...
DECN Accepts 4th Unsolicited Proposition for its GenUltimate TGB Product, and Today Launches its GenUltimate TGB Product into Select International Markets
DECN Awaits Major Proposition On Or About June 10, Notifies Two Entities That Their Earlier Propositions Do Not Meet Requirements,...
Jaguar Health, Inc. Announces 1-for-70 Reverse Stock Split
Shares of Common Stock to Begin Trading on Split-Adjusted Basis on June 7, 2019 SAN FRANCISCO, CA / ACCESSWIRE /...
Resaphene Suisse AG: US Patent Office Announces Patent for Tinnitus Therapy tinniwell
ROGGWIL, SWITZERLAND / ACCESSWIRE / June 5, 2019 / Resaphene Suisse AG, ISIN CH0367465439, WKN A2JG91, has been notified of...
Carbon Black Threat Report Details Cyberattacks Targeting the Healthcare Industry
Report highlights input from 20 leading healthcare CISOs who offer their perspective on evolving cyberattacks, ransomware and the biggest concerns...
Jaguar Health CEO and Board Members Invest in Bridge Financing
SAN FRANCISCO, CA / ACCESSWIRE / June 5, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer
Phase 2 BRACELET-1 study to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and anti-PD-L1 antibody avelumab...
Oncolytics Biotech (R) to Host Conference Call to Discuss Co-Development Agreement with Pfizer and Merck KGaA
SAN DIEGO, CA, and CALGARY, AB / ACCESSWIRE / June 5, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC),...
Hemogenyx Pharmaceuticals PLC Announces CDX Antibody is Effective against AML in vivo
LONDON, UK / ACCESSWIRE / June 5, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces the first data results from...
Angle PLC Announces Completion of Ovarian Cancer Pre-Study
ANGLE plc ("the Company") SUCCESSFUL COMPLETION OF OVARIAN CANCER PRE-STUDY Pre-study demonstrates ANGLE's optimised sample-to-answer molecular solution with patient samples...
Evotec And Celgene Further Expand Ipsc Collaboration Including New Cell Type
INCLUDING NEW CELL TYPES SUPPORTS DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS $ 9.0 M PAYMENT TO EVOTEC HAMBURG,...